Luke Hakes
Investor and Non Executive Director
Octopus VenturesUnited Kingdom
31 investmentsLuke Hakes is an Investor and Non Executive Director at Octopus Ventures based in United Kingdom. Luke Hakes has backed 31 companies, including Antidoteme, Zynstra and UltraSoC Technologies. Investment focus areas include Health Care, E-commerce and Payments.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (31)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Antidoteme | — | — | — | — |
| 2 | Zynstra | — | — | — | — |
| 3 | UltraSoC Technologies | — | — | — | — |
| 4 | MetraSens | — | — | — | — |
| 5 | Seatfrog | — | — | — | — |
| 6 | Surrey NanoSystems | — | — | — | — |
| 7 | Certivox | — | — | — | — |
| 8 | Graze | — | — | — | — |
| 9 | Decoholic | — | — | — | — |
| 10 | Etherapeutics | — | — | — | — |
| 11 | UltraSoc | — | — | — | — |
| 12 | Calastone | — | — | — | — |
Showing 1–12 of 31
Page 1 of 3
Access Full Contact Information
Get Luke Hakes's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.